Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Christopher S. Sauer, Ashley Phetsanthad, Olga L. Riusech & Lingjun Li. (2021) Developing mass spectrometry for the quantitative analysis of neuropeptides. Expert Review of Proteomics 18:7, pages 607-621.
Read now
Read now
Articles from other publishers (27)
Isabelle Bartram, Laura Schnieder, Nils Ellebrecht, Florian Ruland, Tino Plümecke & Andrea zur Nieden. (2023) Categorizing people in the German life sciences: a systematic literature review of classifications of human diversity. Discover Social Science and Health 3:1.
Crossref
Crossref
Joanna K. Malinowska & Tomasz Żuradzki. (2022) Reductionist methodology and the ambiguity of the categories of race and ethnicity in biomedical research: an exploratory study of recent evidence. Medicine, Health Care and Philosophy 26:1, pages 55-68.
Crossref
Crossref
Jasmine H. Hughes, Kara H. Woo, Ron J. Keizer & Srijib Goswami. (2022) Clinical Decision Support for Precision Dosing: Opportunities for Enhanced Equity and Inclusion in Health Care. Clinical Pharmacology & Therapeutics 113:3, pages 565-574.
Crossref
Crossref
Caroline Gombault, Guillaume Grenet, Laure Segurel, Laurent Duret, François Gueyffier, Pascal Cathébras, Dominique Pontier, Sabine Mainbourg, Alicia Sanchez‐Mazas & Jean‐Christophe Lega. (2022) Population designations in biomedical research: Limitations and perspectives. HLA 101:1, pages 3-15.
Crossref
Crossref
Joanna Karolina Malinowska & Tomasz Żuradzki. (2022) Towards the multileveled and processual conceptualisation of racialised individuals in biomedical research. Synthese 201:1.
Crossref
Crossref
Cristina Rodriguez‐Antona, Jessica L. Savieo, Volker M. Lauschke, Katrin Sangkuhl, Britt I. Drögemöller, Danxin Wang, Ron H. N. van Schaik, Andrei A. Gilep, Arul P. Peter, Erin C. Boone, Bronwyn E. Ramey, Teri E. Klein, Michelle Whirl‐Carrillo, Victoria M. Pratt & Andrea Gaedigk. (2022)
PharmVar GeneFocus:
CYP3A5
. Clinical Pharmacology & Therapeutics 112:6, pages 1159-1171.
Crossref
Crossref
Patrick Silva, Deborah Vollmer Dahlke, Matthew Lee Smith, Wendy Charles, Jorge Gomez, Marcia G. Ory & Kenneth S. Ramos. (2022) An Idealized Clinicogenomic Registry to Engage Underrepresented Populations Using Innovative Technology. Journal of Personalized Medicine 12:5, pages 713.
Crossref
Crossref
Innocent G. Asiimwe & Munir Pirmohamed. (2022) Ethnic Diversity and Warfarin Pharmacogenomics. Frontiers in Pharmacology 13.
Crossref
Crossref
Apryl N Anderson, Amy R Chan & Youssef M Roman. (2022) Pharmacogenomics and clinical cultural competency: pathway to overcome the limitations of race. Pharmacogenomics 23:6, pages 363-370.
Crossref
Crossref
Lara Slavec, Nataša Karas Kuželički, Igor Locatelli & Ksenija Geršak. (2022) Genetic markers for non-syndromic orofacial clefts in populations of European ancestry: a meta-analysis. Scientific Reports 12:1.
Crossref
Crossref
Emma F. Magavern, Deepti Gurdasani, Fu L. Ng & Sandra Soo‐Jin Lee. (2021) Health equality, race and pharmacogenomics. British Journal of Clinical Pharmacology 88:1, pages 27-33.
Crossref
Crossref
Everett Lally & Mercy Laurino. 2022. Clinical Decision Support for Pharmacogenomic Precision Medicine. Clinical Decision Support for Pharmacogenomic Precision Medicine
227
240
.
Kelsey S. Lau-Min, Carmen E. Guerra, Katherine L. Nathanson & Justin E. Bekelman. (2021) From Race-Based to Precision Oncology: Leveraging Behavioral Economics and the Electronic Health Record to Advance Health Equity in Cancer Care. JCO Precision Oncology:5, pages 403-407.
Crossref
Crossref
Tiana Luczak, David Stenehjem & Jacob Brown. (2021) Applying an equity lens to pharmacogenetic research and translation to under‐represented populations. Clinical and Translational Science 14:6, pages 2117-2123.
Crossref
Crossref
Bihui Zhang, Min Yang, Tao He, Xuan Li, Jianping Gu, Xiaoming Zhang, Xiangchen Dai, Xuedong Li, Xinwu Lu, Dehai Lang, Hongyao Hu, Xueming Chen, Baozhong Yang, Hongbin Gu, Xiwei Zhang & Yinghua Zou. (2021) Twelve-Month Results From the First-in-China Prospective, Multi-Center, Randomized, Controlled Study of the FREEWAY Paclitaxel-Coated Balloon for Femoropopliteal Treatment. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Katrin Sangkuhl, Karla Claudio‐Campos, Larisa H. Cavallari, Jose A.G. Agundez, Michelle Whirl‐Carrillo, Jorge Duconge, Andria L. Del Tredici, Mia Wadelius, Mariana Rodrigues Botton, Erica L. Woodahl, Stuart A. Scott, Teri E. Klein, Victoria M. Pratt, Ann K. Daly & Andrea Gaedigk. (2021)
PharmVar GeneFocus:
CYP2C9
. Clinical Pharmacology & Therapeutics 110:3, pages 662-676.
Crossref
Crossref
Miguel Luengo-Oroz, Joseph Bullock, Katherine Hoffmann Pham, Cynthia Sin Nga Lam & Alexandra Luccioni. (2021) From Artificial Intelligence Bias to Inequality in the Time of COVID-19. IEEE Technology and Society Magazine 40:1, pages 71-79.
Crossref
Crossref
Mariana R. Botton, Michelle Whirl‐Carrillo, Andria L. Del Tredici, Katrin Sangkuhl, Larisa H. Cavallari, José A. G. Agúndez, Jorge Duconge, Ming Ta Michael Lee, Erica L. Woodahl, Karla Claudio‐Campos, Ann K. Daly, Teri E. Klein, Victoria M. Pratt, Stuart A. Scott & Andrea Gaedigk. (2020)
PharmVar GeneFocus:
CYP2C19
. Clinical Pharmacology & Therapeutics 109:2, pages 352-366.
Crossref
Crossref
Ru-jun Xu, Wei-min Kong, Xiao-fei An, Jian-jun Zou, Li Liu & Xiao-dong Liu. (2020) Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes. Frontiers in Pharmacology 11.
Crossref
Crossref
Eman Thamer Garallah & Sawsan Sajid Al-Jubori. (2020) Surveillance of murA and the plasmid-mediated fosfomycin resistance fosA gene in uropathogenic E. coli isolates from UTI patients. Gene Reports 21, pages 100872.
Crossref
Crossref
O. A. Panibratiuk & O. А. Yakovleva. (2020) Warfarin therapy in patients with coronary heart disease and atrial fibrillation: drug interactions and genetic sensitivity to warfarin. The Ukrainian Biochemical Journal 92:3, pages 77-85.
Crossref
Crossref
Karin Mirzaev, Sherzod Abdullaev, Kristina Akmalova, Jeannette Sozaeva, Elena Grishina, Gregory Shuev, Laura Bolieva, Mariam Sozaeva, Svetlana Zhuchkova, Natalya Gimaldinova, Elena Sidukova, Svetlana Serebrova, Anastasia Asoskova, Alexander Shein, Maria Poptsova, Salavat Suleymanov, Irina Burashnikova, Anastasia Shikaleva, Anastasia Kachanova, Denis Fedorinov & Dmitry Sychev. (2020) Interethnic differences in the prevalence of main cardiovascular pharmacogenetic biomarkers. Pharmacogenomics 21:10, pages 677-694.
Crossref
Crossref
Rashmi R. Shah. (2020) Genotype‐guided warfarin therapy: Still of only questionable value two decades on. Journal of Clinical Pharmacy and Therapeutics 45:3, pages 547-560.
Crossref
Crossref
Shokhrukh Pardaboevich Abdullaev, Karin Badavievich Mirzaev, Irina Sergeevna Burashnikova, Anastasia Alekseevna Shikaleva, Anastasia Alekseevna Kachanova, Sherzod Pardaboevich Abdullaev, Kristina Anatolevna Akmalova, Zhannet Alimonva Sozaeva, Elena Anatolevna Grishina, Maryam Sultan-Hamitovna Sozaeva, Eric Igorevich Rytkin & Dmitry Alekseevich Sychev. (2020) Clinically relevant pharmacogenetic markers in Tatars and Balkars. Molecular Biology Reports 47:5, pages 3377-3387.
Crossref
Crossref
José Jaime Martínez-Magaña, Alma Delia Genis-Mendoza, Jorge Ameth Villatoro Velázquez, Beatriz Camarena, Raul Martín del Campo Sanchez, Clara Fleiz Bautista, Marycarmen Bustos Gamiño, Esbehidy Reséndiz, Alejandro Aguilar, María Elena Medina-Mora & Humberto Nicolini. (2020) The Identification of Admixture Patterns Could Refine Pharmacogenetic Counseling: Analysis of a Population-Based Sample in Mexico. Frontiers in Pharmacology 11.
Crossref
Crossref
Fouzia Radouani, Lyndon Zass, Yosr Hamdi, Jorge da Rocha, Reem Sallam, Sonia Abdelhak, Samah Ahmed, Maryame Azzouzi, Ichrak Benamri, Alia Benkahla, Balkiss Bouhaouala-Zahar, Melek Chaouch, Haifa Jmel, Rym Kefi, Ayoub Ksouri, Judit Kumuthini, Phumlani Masilela, Collen Masimirembwa, Houcemeddine Othman, Sumir Panji, Lilia Romdhane, Chaimae Samtal, Rania Sibira, Kais Ghedira, Faisal Fadlelmola, Samar Kamal Kassim & Nicola Mulder. (2020) A review of clinical pharmacogenetics Studies in African populations. Personalized Medicine 17:2, pages 155-170.
Crossref
Crossref
Noura J. Choudhury, Mansooreh Eghtesad, Sabah Kadri, John Cursio, Lauren Ritterhouse, Jeremy Segal, Aliya Husain & Jyoti D. Patel. (2019) Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center. Oncotarget 10:56, pages 5817-5823.
Crossref
Crossref